Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Macrolides and mycobacterium abscessus abscessus: A good idea?

Langley RJ, Urquhart DS.

Int J Mycobacteriol. 2018 Oct-Dec;7(4):394. doi: 10.4103/ijmy.ijmy_127_18. No abstract available.

2.

Treatment outcomes of macrolide-susceptible Mycobacterium abscessus lung disease.

Choi H, Jhun BW, Kim SY, Kim DH, Lee H, Jeon K, Kwon OJ, Huh HJ, Ki CS, Lee NY, Shin SJ, Daley CL, Koh WJ.

Diagn Microbiol Infect Dis. 2018 Apr;90(4):293-295. doi: 10.1016/j.diagmicrobio.2017.12.008. Epub 2017 Dec 16.

PMID:
29329759
3.

Association between sequevar and antibiotic treatment outcome in patients with Mycobacterium abscessus complex infections in Japan.

Yoshida S, Tsuyuguchi K, Kobayashi T, Tomita M, Inoue Y, Hayashi S, Suzuki K.

J Med Microbiol. 2018 Jan;67(1):74-82. doi: 10.1099/jmm.0.000661. Epub 2017 Dec 11.

PMID:
29227218
4.

Clinical Characteristics and Treatment Outcomes of Patients with Acquired Macrolide-Resistant Mycobacterium abscessus Lung Disease.

Choi H, Kim SY, Kim DH, Huh HJ, Ki CS, Lee NY, Lee SH, Shin S, Shin SJ, Daley CL, Koh WJ.

Antimicrob Agents Chemother. 2017 Sep 22;61(10). pii: e01146-17. doi: 10.1128/AAC.01146-17. Print 2017 Oct.

5.

Outcomes associated with antibiotic regimens for treatment of Mycobacterium abscessus in cystic fibrosis patients.

DaCosta A, Jordan CL, Giddings O, Lin FC, Gilligan P, Esther CR Jr.

J Cyst Fibros. 2017 Jul;16(4):483-487. doi: 10.1016/j.jcf.2017.04.013. Epub 2017 May 8.

6.

Non-Tuberculous Mycobacteria multispecies biofilms in cystic fibrosis: development of an in vitro Mycobacterium abscessus and Pseudomonas aeruginosa dual species biofilm model.

Rodríguez-Sevilla G, García-Coca M, Romera-García D, Aguilera-Correa JJ, Mahíllo-Fernández I, Esteban J, Pérez-Jorge C.

Int J Med Microbiol. 2018 Apr;308(3):413-423. doi: 10.1016/j.ijmm.2018.03.003. Epub 2018 Mar 6.

PMID:
29555180
7.

Mycobacterium abscessus and massiliense lung infection during macrolide treatment for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation.

Miyake N, Chong Y, Nishida R, Takenaka K, Kato K, Miyamoto T, Aono A, Takaki A, Mitarai S, Shimoda S, Shimono N, Akashi K.

J Infect Chemother. 2018 Jan;24(1):78-81. doi: 10.1016/j.jiac.2017.08.011. Epub 2017 Oct 6.

PMID:
28988958
8.

Mycobacteriological characteristics and treatment outcomes in extrapulmonary Mycobacterium abscessus complex infections.

Jeong SH, Kim SY, Huh HJ, Ki CS, Lee NY, Kang CI, Chung DR, Peck KR, Shin SJ, Koh WJ.

Int J Infect Dis. 2017 Jul;60:49-56. doi: 10.1016/j.ijid.2017.05.007. Epub 2017 May 15.

9.

Compassionate Nitric Oxide Adjuvant Treatment of Persistent Mycobacterium Infection in Cystic Fibrosis Patients.

Yaacoby-Bianu K, Gur M, Toukan Y, Nir V, Hakim F, Geffen Y, Bentur L.

Pediatr Infect Dis J. 2018 Apr;37(4):336-338. doi: 10.1097/INF.0000000000001780.

PMID:
28885458
10.

The importance of early diagnosis of Mycobacterium abscessus complex in patients with cystic fibrosis.

Ravnholt C, Kolpen M, Skov M, Moser C, Katzenstein TL, Pressler T, Høiby N, Qvist T.

APMIS. 2018 Dec;126(12):885-891. doi: 10.1111/apm.12903. Review.

PMID:
30456869
11.

Systematic Review and Meta-analyses of the Effect of Chemotherapy on Pulmonary Mycobacterium abscessus Outcomes and Disease Recurrence.

Pasipanodya JG, Ogbonna D, Ferro BE, Magombedze G, Srivastava S, Deshpande D, Gumbo T.

Antimicrob Agents Chemother. 2017 Oct 24;61(11). pii: e01206-17. doi: 10.1128/AAC.01206-17. Print 2017 Nov.

12.

Molecular typing of Mycobacterium Abscessus isolated from cystic fibrosis patients.

Trovato A, Baldan R, Costa D, Simonetti TM, Cirillo DM, Tortoli E.

Int J Mycobacteriol. 2017 Apr-Jun;6(2):138-141. doi: 10.4103/ijmy.ijmy_33_17.

13.

Controlling Extra- and Intramacrophagic Mycobacterium abscessus by Targeting Mycolic Acid Transport.

Viljoen A, Herrmann JL, Onajole OK, Stec J, Kozikowski AP, Kremer L.

Front Cell Infect Microbiol. 2017 Sep 1;7:388. doi: 10.3389/fcimb.2017.00388. eCollection 2017.

14.

Multidrug-resistant Mycobacterium abscessus threatens patients with cystic fibrosis.

van Dorn A.

Lancet Respir Med. 2017 Jan;5(1):15. doi: 10.1016/S2213-2600(16)30444-1. Epub 2016 Dec 10. No abstract available.

PMID:
27956215
15.

The drug susceptibility profile and inducible resistance to macrolides of Mycobacterium abscessus and Mycobacterium massiliense in Korea.

Kim SY, Kim CK, Bae IK, Jeong SH, Yim JJ, Jung JY, Park MS, Kim YS, Kim SK, Chang J, Kang YA.

Diagn Microbiol Infect Dis. 2015 Feb;81(2):107-11. doi: 10.1016/j.diagmicrobio.2014.10.007. Epub 2014 Oct 25.

PMID:
25467784
16.

Mycobacterium abscessus in patients with cystic fibrosis: low impact of inter-human transmission in Italy.

Tortoli E, Kohl TA, Trovato A, Baldan R, Campana S, Cariani L, Colombo C, Costa D, Cristadoro S, Di Serio MC, Manca A, Pizzamiglio G, Rancoita PMV, Rossolini GM, Taccetti G, Teri A, Niemann S, Cirillo DM.

Eur Respir J. 2017 Jul 13;50(1). pii: 1602525. doi: 10.1183/13993003.02525-2016. Print 2017 Jul. No abstract available.

17.

Radiologic computed tomography features of Mycobacterium abscessus in cystic fibrosis.

Lam DL, Kapnadak SG, Godwin JD, Kicska GA, Aitken ML, Pipavath SN.

Clin Respir J. 2018 Feb;12(2):459-466. doi: 10.1111/crj.12536. Epub 2016 Aug 22.

PMID:
27460837
18.

Activities of moxifloxacin in combination with macrolides against clinical isolates of Mycobacterium abscessus and Mycobacterium massiliense.

Choi GE, Min KN, Won CJ, Jeon K, Shin SJ, Koh WJ.

Antimicrob Agents Chemother. 2012 Jul;56(7):3549-55. doi: 10.1128/AAC.00685-12. Epub 2012 May 7.

19.

Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients.

Roux AL, Catherinot E, Soismier N, Heym B, Bellis G, Lemonnier L, Chiron R, Fauroux B, Le Bourgeois M, Munck A, Pin I, Sermet I, Gutierrez C, Véziris N, Jarlier V, Cambau E, Herrmann JL, Guillemot D, Gaillard JL; OMA group.

J Cyst Fibros. 2015 Jan;14(1):63-9. doi: 10.1016/j.jcf.2014.07.004. Epub 2014 Jul 30.

20.

Antagonism between Front-Line Antibiotics Clarithromycin and Amikacin in the Treatment of Mycobacterium abscessus Infections Is Mediated by the whiB7 Gene.

Pryjma M, Burian J, Kuchinski K, Thompson CJ.

Antimicrob Agents Chemother. 2017 Oct 24;61(11). pii: e01353-17. doi: 10.1128/AAC.01353-17. Print 2017 Nov.

Supplemental Content

Support Center